Federal National Mortgage Association
FNMA · OTC
About FNMA
- Employees
- 7,000
- Headquarters
- WASHINGTON, Washington Dc
- Listed
- Mar 17, 1980
- Sector
- Financials
- Industry
- Financial Services
- Website
- fanniemae.com
FNMA key statistics
- Market cap
- 3.96B
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 5.82M
- Volume
- 8.09M
- Open price
- $3.43
- High today
- $3.99
- Low today
- $3.30
- 52 Week high
- $12.87
- 52 Week low
- $2.96
Federal National Mortgage Association (FNMA) at a glance
As of Oct 20, 2026, Federal National Mortgage Association (FNMA) shares are priced at $3.73, giving the company a market cap of 3.96B and a price-to-earnings ratio of 0.00.
Today the stock has traded between $3.30 and $3.99. The current price is 13.0% above the day's low and 6.5% below its high.
Volume so far is 8.09M shares, above the average of 5.82M shares a day.
Over the past year Federal National Mortgage Association has ranged from $2.96 to $12.87, and now sits 8% of the way up that range.
Federal National Mortgage Association met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.65 per share against an estimate of $0.6426.
The average analyst price target is $9.56, 156.4% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy25.0%
- Hold50.0%
- Sell25.0%
- Low
- $6.31
- Now
- $3.73
- High
- $18.90
FNMA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 4.1% on average.
- Q3 FY24: reported $0.69 per share against an estimate of $0.6528
- Q4 FY24: reported $0.70 per share against an estimate of $0.663
- Q1 FY25: reported $0.62 per share against an estimate of $0.6854
- Q2 FY25: reported $0.57 per share against an estimate of $0.6905
- Q3 FY25: reported $0.65 per share against an estimate of $0.7058
- Q4 FY25: reported $0.50 per share against an estimate of $0.663
- Q1 FY26: reported $0.62 per share against an estimate of $0.6452
- Q2 FY26: reported $0.65 per share against an estimate of $0.6426
FNMA news
- Tanya Rawat
- Tanya Rawat
Peter Schiff Sees 'Disaster Waiting to Happen' in Housing Market as Fannie Mae, Freddie Mac Shares Tumble, Says Home Prices Will Have to 'Implode'
- Rishabh Mishra
Michael Burry Warns Fannie Mae and Freddie Mac Could Become ‘Worthless’ as Trump-Era Gains Collapse Under Fresh Pressure
- Press releasePRNewswire
Fannie Mae Announces Sale of Non-Performing Loans
- Press releasePRNewswire
Fannie Mae Announces Results of Tender Offer for Any and All of Certain CAS Notes
- Press releasePRNewswire
Fannie Mae Announces Winner of Twenty-Eighth Community Impact Pool of Non-Performing Loans
- Press releasePRNewswire
Fannie Mae Announces Tender Offer for Any and All of Certain CAS Notes
- Press releasePRNewswire
Fannie Mae Releases August 2026 Monthly Summary
Similar companies
Companies in the same industry as Federal National Mortgage Association
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.